Virulence Factors and Molecular Identification of Candida Species Causing Candidemia in Honduras

José Fernando Chávez1, Bryan Ortiz1, Roque López2

  • 1Instituto de Investigaciones en Microbiología, Facultad de Ciencias, Universidad Nacional Autónoma de Honduras, Tegucigalpa 11101, Honduras.

PubMed

Insights

Invasive fungal infections in Honduras are increasingly caused by non-albicans Candida species. Accurate molecular identification is crucial for effective antifungal treatment and surveillance.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Public Health Microbiology

Background:

  • Invasive fungal infections (IFIs) pose a significant global health threat, particularly those caused by Candida species.
  • High mortality rates and increasing antifungal resistance are major concerns.
  • Epidemiological data on IFIs in Honduras is limited.

Purpose of the Study:

  • To characterize Candida species causing candidemia in Honduras.
  • To assess key virulence factors of isolated Candida strains.
  • To inform local antifungal therapy and surveillance strategies.

Main Methods:

  • Collected 80 clinical Candida isolates from four hospitals in Tegucigalpa and San Pedro Sula, Honduras.
  • Employed both phenotypic and molecular methods for species identification.
  • Assessed virulence factors including hemolytic activity, phospholipase and protease production, and biofilm formation.

Main Results:

  • Candida albicans and Candida tropicalis were the most common species (30% each), followed by Candida parapsilosis (27.5%).
  • Phenotypic identification methods showed a 13.8% misidentification rate.
  • Most isolates (96.3%) displayed strong hemolytic activity; C. albicans had the highest phospholipase activity, and C. tropicalis exhibited the most robust biofilm formation.

Conclusions:

  • Honduras shows an evolving Candida epidemiology with a rise in non-albicans species, potentially impacting antifungal susceptibility.
  • Diverse virulence profiles, including significant biofilm formation, were observed.
  • Accurate molecular diagnostics and continuous surveillance are essential for guiding antifungal therapy and developing localized interventions.